Click: 81

Search: 33

This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Pharmaceutical Sales
Product Knowledge
Interpersonal Skills
Networking
Ethics
Specialization
High-Value Selling
Sales Strategy
CRM

Pharma Rep Focus

Expert insights. Personalized for you.

brought to you by

Accreditation Council for Medical Affairs

brought to you by Accreditation Council for Medical Affairs

Search:

See the top articles from:

DAY

WEEK

MONTH

YEAR

MORE monthly editions

MORE yearly editions

Select your country:
Sign up | Log in

Search:

Select your country:

Topics
Resources
- On-Demand Webinars
- White Papers/eBooks/Guides
  - Have resources to share?
    Submit Your Own!
- Widgets
  - Build a Widget
  - Build a Content Widget
Learn More
What's This?

Sign up | Log in
Topics
Resources
- Webinar Series
  - See All
- White Papers/eBooks/Guides
  - Have resources to share?
    Submit Your Own!
- Widgets
  - Build a Widget
  - Build a Content Widget
Learn More
What's This?
See all the top articles from
- DAY
- WEEK
- MONTH
- YEAR
  - This Year
  - Last Year
  - 2022
  - 2021
  - 2020
  - 2019

Mon.Apr 29, 2024

fda-biopharma

Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency

MedCity News

APRIL 29, 2024

The FDA approved X4 Pharmaceuticals drug Xolremdi for treating WHIM syndrome. The post Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency appeared first on MedCity News.

FDA

FDA Pharmaceutical Biopharma Pharma

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About

Learn More
Participate in Pharma Rep Focus
Support
Add a Source
Add a Resource
Advertise

About

Learn More
Participate in Pharma Rep Focus
Support
Add a Source
Add a Resource
Advertise

Editions

Thu. May 16
Wed. May 15
Tue. May 14
Mon. May 13
May 04 - May 10

Editions

Thu. May 16
Wed. May 15
Tue. May 14
Mon. May 13
May 04 - May 10

Topics

Sales Management
Biopharma
Law & Regulation
B2B Sales
More Topics

Input your email to sign up, or if you already have an account, log in here!

Remember me I forgot my password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Enter your email address to reset your password.
A temporary password will be e‑mailed to you.

Nevermind, I remember my password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BE IN THE KNOW ON

Pharma Rep Focus

Expert insights. Personalized for you.

We organize all of the trending information in your field so you don't have to.
Join 8,000+ users and stay up to date on the latest articles your peers are reading.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Newsletter
About You
Verify
Interests
Company

Get the good stuff

Subscribe to the following Pharma Rep Focus newsletters:

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

You must accept the Privacy Policy and Terms & Conditions to proceed.

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

If you do provide consent, you may change your mind and unsubscribe at any time. If you would like to unsubscribe or have any questions, you can click on the unsubscribe links in our messages or contact us using the information below. For information about how we use information you provide to us, please read our Privacy Policy.

For Canadian Residents: By providing your consent below, you are expressly agreeing that we may email you under Canada's Anti-Spam Law. For more information on this law, you may visit the Government of Canada's site.

For European Union Residents: By providing your consent below, you are expressly agreeing that we may email you under European Union General Data Protection Regulation (Regulation (EU) 2016/679). For more information on this regulation, you may visit the European Union's site. Additional details.

Contact Information:
Aggregage
info@aggregage.com
525 South Douglas St., Suite 260, El Segundo, CA 90245

You know about us, now we want to get to know you!

Check your mail

We've sent an email to . Please verify that you have received the email.

We have resent the email to

Let's personalize your content

Use social media to find articles

We can use your profile and the content you share to understand your interests and provide content that is just for you.

Turn this off at any time. Your social media activity always remains private.

Let's get even more personalized

Choose topics that interest you.

So, what do you do?

Are you sure you want to cancel your subscriptions?

Changing Country?

Accept Terms & Conditions

It looks like you are changing your country/region of residence. In order to receive our emails, you must expressly agree. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of our emails.

You appear to have previously removed your acceptance of the Terms & Conditions.

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

We noticed that you changed your country/region of residence; congratulations! In order to make this change, you must accept the Aggregage Terms and Conditions and Privacy Policy. Once you've accepted, then you will be able to choose which emails to receive from each site.

You appear to have previously removed your acceptance of the Terms & Conditions.

You must choose one option

Agree to Terms and Conditions and Privacy Policy

Cancel country change

Cancel all of my subscriptions

Please choose which emails to receive from each site.

Update All Sites
Update Each Site

Please verify your previous choices for all sites

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

Sites have been updated - click Submit All Changes below to save your changes.

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

Newsletter
About You
Interests

Get the good stuff

Subscribe to the following Pharma Rep Focus newsletters:

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

You must accept the Privacy Policy and Terms & Conditions to proceed.

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

You know about us, now we want to get to know you!

We've sent an email to . Please verify that you have received the email.

We have resent the email to

Let's personalize your content

Use social media to find articles

We can use your profile and the content you share to understand your interests and provide content that is just for you.

Turn this off at any time. Your social media activity always remains private.

Let's get even more personalized

Choose topics that interest you.

We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.

Subscribe to the following Pharma Rep Focus newsletters:

Daily

Weekly

Resources: Webinars, eBooks, White Papers

Personalize my articles

You must accept the Privacy Policy and Terms & Conditions to proceed.

Agree to Terms and Conditions and Privacy Policy

We request your consent to allow us to send you newsletters and resources (webinars, eBooks, white papers) to the email address you have provided.

This is not me

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.